METHOD OF ESTIMATION OF CONDITION OF APOPTOPIC SYSTEM IN SKIN AT SICK WITH PSORIASIS Russian patent published in 2009 - IPC A61B10/00 G01N33/52 

Abstract RU 2343840 C2

FIELD: medicine; dermatology.

SUBSTANCE: freeze samples from the damaged part of the skin in liquid nitrogen, crush, not supposing defrosting, from assays allocate total cellular water-soluble fibers with use of the lysing buffer containing 50 mM HEPES, pH 7.4, 5 mM CHAPS, 5 mM DTT in a current of 1 hour at +4°C, centrifugate the lyzed admixture, remove supernatant fluid and define quantity of total protein using the Bradford's technique, then define activity of caspase-3 a colorimetric method by definition of one of reaction products between caspase-3 and a peptide acetyl-asp-glu-shaft-asp p-nitroaniline (Ac-DEVD-pNA) - p-nitroaniline for what in the small cavity of a 96-cup tablet bring 85 mcl Assay buffer: 20 mM HEPES, pH 7.4, 2 mM EDTA, 0.1% CHAPS, 5 mM DTT and 5 mcl cellular lysate, add 10 mcl substrate caspase-3: 20 mM Ac-DEVD-pNa in dimethyl sulfoxide in each small cavity and incubate an admixture of 90 minutes at 37°C, then measure optical density (OD) at 405 nanometers in each of the small cavities on the ELISA reader then count activity of the kaspase-3 under the formula: activity, micron of pNA/minutes/ml = (OD*d)/(t*v*ε), on mkg of total fiber, where: OD - the optical density, d - the dilution factor, t - reaction time in mines, v - assay volume in ml, ε - 10.5 mM, thus one unit of activity of enzyme is peer to splitting 1 micromole substrate Ac-DEVD-pNA for 1 minute at pH 7.4 and 25°C, on value of received size estimate condition of the apoptotic system and at normal value of this indicator - 0.5-0.6 un/mkg of the protein of apoptotic system estimate condition as stable, and at its rising more, than on 30-40% - as activated.

EFFECT: possibility objectively and precisely to define level of the main apoptotic protein in the damaged skin in the psoriasis centres, to estimate degree of expression of pathological process, sensitivity of a skin immediately in the psoriasis centres to action of exogenous damaging factors and to pick up individual skins adequate to a given condition, the therapy referred on depression of rate of apoptotic reactions and according to activity of pathological process.

1 ex

Similar patents RU2343840C2

Title Year Author Number
METHOD FOR EVALUATING THE STATE OF CUTANEOUS APOPTIC SYSTEM IN PSORIASIS-SUFFERING PATIENTS 2006
  • Korsunskaja Irina Markovna
  • Goldenkova Irina Vasil'Evna
  • Bruskin Sergej Aleksandrovich
  • Piruzjan Anastas Levonovich
  • Egorenkova Ljubov' Vladimirovna
  • Olejnik Svetlana Sergeevna
  • Togoeva Laura Tejmurazovna
  • Abdeev Rustam Muratovich
RU2311643C1
METHOD OF OBTAINING BIOPSY MATERIAL FROM ATHEROSCLEROSIS-AFFECTED VESSELS 2008
  • Sarkisova Marina Karlenovna
  • Sobolev Vladimir Vasil'Evich
  • Piruzjan Ehleonora Surenovna
  • Korsunskaja Irina Markovna
  • Golukhova Elena Zelikovna
  • Sautin Maksim Evgen'Evich
  • Serov Roman Andreevich
  • Abdeev Rustam Muratovich
RU2387384C1
METHOD FOR OBTAINING CASPASE-3 2022
  • Granovskij Igor Eduardovich
  • Kalinin Danil Sergeevich
  • Majorov Sergej Gennadevich
  • Shlyapnikov Mikhail Grigorevich
  • Rabushko Elizaveta Nikolaevna
RU2792795C1
DIPEPTIDYL PEPTIDASE IV INHIBITING AGENT AND PHARMACEUTICAL COMPOSITION THEREOF 2011
  • Kreminskaja Vera Mikhajlovna
  • Zolotov Nikolaj Nikolaevich
RU2485952C2
METHOD FOR CORRECTING ATHEROGENESIS EXPERIMENTALLY USING 1-HYDROXYGERMATRANE 2020
  • Rachin Andrei Petrovich
  • Rasulov Rizo Maksudovich
  • Baryshok Viktor Petrovich
  • Storozhenko Pavel Arkadevich
  • Rasulov Maksud Mukhamedzhanovich
  • Zhigacheva Irina Valentinovna
  • Korsunskaia Irina Markovna
  • Piruzian Anastas Levonovich
  • Lebedeva Olga Danialovna
  • Kostromina Elena Iurevna
RU2741229C1
METHOD FOR DEVELOPING ALZHEIMER DISEASE CELL MODELS 2013
  • Kozin Sergej Aleksandrovich
  • Petrushanko Irina Igorevna
  • Simonenko Ol'Ga Vasil'Evna
  • Mit'Kevich Vladimir Aleksandrovich
  • Kulikova Aleksandra Aleksandrovna
  • Egorov Egor Evgen'Evich
  • Vishnjakova Khava Safiullovna
  • Tsvetkov Filipp Olegovich
  • Makarov Aleksandr Aleksandrovich
RU2544957C2
METHOD OF ISOLATION OF HIGH-MOLECULAR PROTEIN ACTIVATION COMPLEX OF HUMAN CASPASE-2 2016
  • Kopeina Gelina Sergeevna
  • Zamaraev Aleksej Vladimirovich
  • Lavrik Inna Nikolaevna
  • Zhivotovskij Boris Davidovich
RU2671510C1
1-HYDROXYGERMATRANE USAGE FOR INHIBITING THE DEVELOPMENT OF ATHEROSCLEROSIS IN THE EXPERIMENT 2020
  • Fesiun Anatolii Dmitrievich
  • Rasulov Rizo Maksudovich
  • Baryshok Viktor Petrovich
  • Storozhenko Pavel Arkadevich
  • Rasulov Maksud Mukhamedzhanovich
  • Zhigacheva Irina Valentinovna
  • Korsunskaia Irina Markovna
  • Piruzian Anastas Levonovich
  • Kniazeva Tatiana Aleksandrovna
  • Iakupova Regina Dimianovna
RU2742972C1
USE OF 1-(GERMATRAN-1-YL)-1-HYDROXYETHYLAMINE FOR INHIBITING THE DEVELOPMENT OF ATHEROSCLEROSIS IN THE EXPERIMENT 2020
  • Rachin Andrei Petrovich
  • Rasulov Rizo Maksudovich
  • Baryshok Viktor Petrovich
  • Storozhenko Pavel Arkadevich
  • Rasulov Maksud Mukhamedzhanovich
  • Zhigacheva Irina Valentinovna
  • Kuznetsov Igor Anatolevich
  • Korsunskaia Irina Markovna
  • Piruzian Anastas Levonovich
  • Gilmutdinova Ilmira Rinatovna
  • Apkhanova Tatiana Valerevna
RU2746321C1
COMPOSITION COMPRISING MIXTURE OF CD95-FC ISOFROMS 2013
  • Khill Oliver
  • Giffers Kristian
  • Timann Majnolf
RU2648157C2

RU 2 343 840 C2

Authors

Korsunskaja Irina Markovna

Bruskin Sergej Aleksandrovich

Piruzjan Anastas Levonovich

Egorenkova Ljubov' Vladimirovna

Olejnik Svetlana Sergeevna

Togoeva Laura Tejmurazovna

Abdeev Rustam Muratovich

Dates

2009-01-20Published

2006-12-21Filed